Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-12-01T04:46:54.305Z Has data issue: false hasContentIssue false
  • English
  • Français

Failure of Oral Antimicrobial Agents in Eradicating Gastrointestinal Colonization With Vancomycin-Resistant Enterococci

Published online by Cambridge University Press:  02 January 2015

Ray Hachem  and
Issam Raad
Ray Hachem
Affiliation:
Section of Infection Control, Department of Internal Medicine Specialties, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Issam Raad*
Affiliation:
Section of Infection Control, Department of Internal Medicine Specialties, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
*
Professor of Medicine, The University of Texas M.D. Anderson Cancer Center, Department of Infection Diseases, Infection Control and Employee Health (Box 402), 1515 Holcombe Blvd., Houston, TX 77030
Get access Rights & Permissions [Opens in a new window]

Abstract

Eradication of gastrointestinal colonization with vancomycin-resistant enterococci (VRE) using a combination of oral bacitracin and gentamicin was evaluated. Twenty-eight evaluable treated patients were matched with 28 control patients. After 3 months of follow-up, 5 patients (18%) in the treatment group versus 1 patient (4%) in the control group (P = .2) had negative results on stool cultures, with a similar frequency of VRE bacteremia (P = .8). The use of oral bacitracin plus gentamicin did not reduce VRE colonization or bacteremia.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 23 , Issue 1 , January 2002 , pp. 43 - 44
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin—United States, 1989-93. MMWR 1993;42:597–609.Google Scholar
2.Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995;44(RR-12):1–13.Google Scholar
3.Weinstein, MR, Dedier, H, Brunton, J, Campbell, I, Conly, JM. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1999;29:361–366.Google Scholar
4.O'Donovan, CA, Fan-Havard, P, Tecson-Tumang, FT, Smith, SM, Eng, RH. Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis 1994;18:105–109.Google Scholar
5.Montecalvo, MA, Horowitz, H, Wormser, GP, Seiter, K, Carbonaro, CA. Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 1995;39:794.CrossRefGoogle ScholarPubMed
6.Chia, JKS, Nakata, MM, Park, S, Lewis, RP, Mckee, B. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1995;21:1520.Google Scholar
7.Wong, MT, Kauffman, CA, Standiford, HC, et al. Clinical efficacy and safety of a novel glycopeptide, ramoplanin, in the contamination of the gastrointestinal system of patients colonized with vancomycin-resistant Enterococcus. Clin Infect Dis 1999;29:968.Google Scholar
8.Facklam, RR, Collins, MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989;27:731–734.CrossRefGoogle ScholarPubMed
9.National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard, 3rd ed. Villanova, PA: National Committee for Clinical Laboratory Standards; 1993. NCCLS document M7-A3.Google Scholar